News

Regulatory affairsRegulatory Round-up - March 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
July newsletterJuly newsletterApril newsletterApril newsletterMarch newsletterMarch newsletterQuality Control in cell and gene therapy manufacturingQuality Control in cell and gene therapy manufacturingPress Release: Cell and Gene Therapy Catapult research highlights the UK’s growing global leadership in innovative cell and gene therapy industryPress Release: Cell and Gene Therapy Catapult research highlights the UK’s growing global leadership in innovative cell and gene therapy industryInside the Work of UK Innovation CentresInside the Work of UK Innovation CentresCGT Catapult enters into regenerative medicines partnership with Global Stem Cells and Regenerative Medicine Acceleration CenterCGT Catapult enters into regenerative medicines partnership with Global Stem Cells and Regenerative Medicine Acceleration CenterGovernment announces new accelerated access schemeGovernment announces new accelerated access schemeRegulatory news - October 2017Regulatory news - October 2017Press Release: Cell and Gene Therapy Catapult Annual Review Reveals Burgeoning UK Cell and Gene Medicines SectorPress Release: Cell and Gene Therapy Catapult Annual Review Reveals Burgeoning UK Cell and Gene Medicines SectorInnovation in operating models – the Cell and Gene Therapy Catapult manufacturing centreInnovation in operating models – the Cell and Gene Therapy Catapult manufacturing centrePress Release: iPSC line licensed to Universal Cells to assist in the development of universal donor cell linePress Release: iPSC line licensed to Universal Cells to assist in the development of universal donor cell line